Verona Pharma plc
VRNA
$105.27
$0.070.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.26% | 57.49% | 47.09% | 30.57% | 49.45% |
| Total Receivables | 2,259.36% | 494.14% | 240.13% | 31.35% | -63.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 110.42% | 212.45% | 109.37% | 139.02% | 507.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.31% | 590.93% | -18.72% | -45.51% | -57.49% |
| Total Current Assets | 31.84% | 84.31% | 56.56% | 31.72% | 44.63% |
|
|
|||||
| Total Current Assets | 31.84% | 84.31% | 56.56% | 31.72% | 44.63% |
| Net Property, Plant & Equipment | 12.20% | 13.10% | 9.82% | 407.54% | 313.38% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 31.96% | 81.41% | 53.91% | 30.55% | 42.84% |
|
|
|||||
| Total Accounts Payable | -17.29% | 95.16% | 222.62% | 730.01% | 66.55% |
| Total Accrued Expenses | 136.45% | 345.30% | 398.10% | 147.56% | 162.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.65% | -3.58% | 53.14% | 153.19% | 89.17% |
| Total Finance Division Other Current Liabilities | -98.41% | 1,199.86% | 2,601.38% | 345.91% | 5,200.23% |
| Total Other Current Liabilities | -98.41% | 1,199.86% | 2,601.38% | 345.91% | 5,200.23% |
| Total Current Liabilities | 5.98% | 282.73% | 391.04% | 210.14% | 341.56% |
|
|
|||||
| Total Current Liabilities | 5.98% | 282.73% | 391.04% | 210.14% | 341.56% |
| Long-Term Debt | 102.56% | 397.96% | 366.70% | 502.91% | 502.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.35% | -34.23% | -30.08% | 6,645.00% | 4,826.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.81% | 361.06% | 358.32% | 768.53% | 762.14% |
|
|
|||||
| Common Stock & APIC | 29.05% | 25.74% | 20.10% | 3.34% | 3.38% |
| Retained Earnings | -16.85% | -39.67% | -44.79% | -41.28% | -35.13% |
| Treasury Stock & Other | 4.12% | -2.04% | -2.32% | -1.53% | -4.09% |
| Total Common Equity | 65.37% | 0.71% | -17.94% | -50.48% | -38.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 65.37% | 0.71% | -17.94% | -50.48% | -38.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 65.37% | 0.71% | -17.94% | -50.48% | -38.38% |
|
|
|||||